Elite Pharmaceuticals, Inc. · 1 day ago
Sr. Scientist Analytical R&D
Northvale, NJ
Full-time
Onsite
Senior LevelElite Pharmaceuticals, Inc. specializes in developing oral sustained and controlled release drug formulations. The Sr. Scientist Analytical R&D will develop and validate analytical methods, conduct testing for drug formulations, and ensure compliance with GMP standards while collaborating with cross-functional teams.
BiotechnologyMedicalPharmaceutical
Hiring Manager
Rafiqul Islam, PhD
Responsibilities
Develop and validate analytical methods
Conduct analytical testing for drug formulations
Work in compliance with GMP standards
Design and execute laboratory experiments
Ensure the accuracy of analytical data
Contribute to the development of high-quality pharmaceutical products
Collaborate with cross-functional teams to support research and development efforts
Qualification
Required
Expertise in Analytical Methods Development and Method Development
Strong Analytical Skills and Laboratory Skills to ensure precision and accuracy in experimental work
Experience with and adherence to Good Manufacturing Practice (GMP) regulations
Ability to handle complex research projects, meet deadlines, and manage multiple priorities effectively
Advanced degree (Ph.D./Master's) in Chemistry, Pharmaceutical Sciences, or a related field, with relevant industry experience
Knowledge of FDA regulations, analytical instrumentation, and pharmaceutical testing techniques
Excellent communication and report-writing skills
Company
Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals, Inc. develops oral sustained and controlled release products.
Founded in 1996
11-50 employees
H1B Sponsorship
Elite Pharmaceuticals, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
2023 (1)
Funding
Current Stage
Public CompanyTotal Funding
$7.51MKey Investors
Crede CapitalGroup
2020-07-13Post Ipo Equity· $0.5M
2014-04-15Post Ipo Equity· $0.8M
2013-04-23Post Ipo Equity· $0.21M
Leadership Team
Carter Ward
Chief Financial Officer
Recent News
2025-11-13
Company data provided by crunchbase